Click on the interactive chart below to see data over time.
2. Gentium S.p.A ( GENT): Focuses on the development and manufacture of its primary product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded DNA extracted from pig intestines. Market cap at $429.66M, most recent closing price at $28.37.
3. Luxottica Group SpA ( LUX): Provides luxury and sport/performance eyewear worldwide. Market cap at $25.26B, most recent closing price at $53.50.
( List compiled by James Dennin, a Kapitall writer. Analyst ratings sourced from Zacks Investment Research, all other data sourced from Finviz.)